Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983

European Journal of Cancer

Volumn 50, Issue 5, 2014, Pages 912-919

  Tanis, E ^a   Nordlinger, B ^b   Mauer, M ^c   Sorbye, H ^d   Van Coevorden, F ^e   Gruenberger, T ^f   Schlag, P M ^g   Punt, C J A ^h   Ledermann, J ⁱ   Ruers, T J M ^e  

^a EORTC DATA CENTER   (Belgium)

^b HÔPITAL AMBROISE PARÉ   (France)

^c EORTC Headquarters ^*  (Belgium)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g HUMBOLDT UNIVERSITY   (Germany)

^h UNIVERSITY OF AMSTERDAM   (Netherlands)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Colorectal liver metastases; Local recurrence; Radiofrequency ablation; Resection

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER RESEARCH; CANCER SURGERY; CANCER THERAPY; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; EUROPE; FEMALE; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; TUMOR VOLUME;

COLORECTAL LIVER METASTASES; LOCAL RECURRENCE; RADIOFREQUENCY ABLATION; RESECTION;

ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETER ABLATION; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84896736439     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.12.008     Document Type: Article

References (16)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 4 2010 765 781
2. World Health Organisation. The global burden of disease: 2004 update. WHO; 2008.
3. E.K. Abdalla, J.N. Vauthey, and L.M. Ellis et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 6 2004 818 825
4. A.L. Gleisner, M.A. Choti, L. Assumpcao, H. Nathan, R.D. Schulick, and T.M. Pawlik Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection- radiofrequency ablation Arch Surg 143 12 2008 1204 1212
5. T. Ruers, C. Punt, and C.F. van et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004) Ann Oncol 23 10 2012 2619 2626
6. A. Stang, R. Fischbach, W. Teichmann, C. Bokemeyer, and D. Braumann A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases Eur J Cancer 45 10 2009 1748 1756
7. J.P. Guenette, and D.E. Dupuy Radiofrequency ablation of colorectal hepatic metastases J Surg Oncol 102 8 2010 978 987
8. A. Ahmad, S.L. Chen, M.A. Kavanagh, D.P. Allegra, and A.J. Bilchik Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better? Am Surg 72 10 2006 875 879
9. P. Abitabile, U. Hartl, J. Lange, and C.A. Maurer Radiofrequency ablation permits an effective treatment for colorectal liver metastasis Eur J Surg Oncol 33 1 2007 67 71
10. R.T. Poon, K.K. Ng, and C.M. Lam et al. Learning curve for radiofrequency ablation of liver tumours: prospective analysis of initial 100 patients in a tertiary institution Ann Surg 239 4 2004 441 449
11. T.J. Ruers, J.J. Joosten, and B. Wiering et al. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study Ann Surg Oncol 14 3 2007 1161 1169
12. B. Nordlinger, H. Sorbye, and B. Glimelius et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 9617 2008 1007 1016
13. S. Mulier, Y. Ni, J. Jamart, T. Ruers, G. Marchal, and L. Michel Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors Ann Surg 242 2 2005 158 171
14. L. Solbiati, T. Ierace, M. Tonolini, and L. Cova Guidance and monitoring of radiofrequency liver tumour ablation with contrast-enhanced ultrasound Eur J Radiol 51 Suppl. 2004 S19 S23
15. S.L. Wong, P.B. Mangu, and M.A. Choti et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer J Clin Oncol 28 3 2010 493 508
16. S. Mulier, T. Ruers, J. Jamart, L. Michel, G. Marchal, and Y. Ni Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update Dig Surg 25 6 2008 445 460